企業

Nexentis Technologies Inc.

フォロー構造マップを開くこれについて質問この企業をリサーチ

Nexentis Technologies Inc. の構造

Nexentis Technologies Inc.

企業

所有投資と保有1

関係

矢印は関係の方向を示します。分野で絞り込めます。

Nexentis Technologies Inc.を所有 →MitoCareX Bio
企業 · MitoCareX Bio根拠 2
事実90%
証拠を見る
- 企業開示GlobeNewswire public company news2026-10-07 19:32
  Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
  出典を見る
- 企業開示GlobeNewswire public company news2026-10-07 19:32
  MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
  出典を見る
Nexentis Technologies Inc.に投資 →solar projects
施設 · solar projects根拠 1
事実90%
証拠を見る
- 企業開示GlobeNewswire public company news2026-10-07 19:32
  The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
  出典を見る

2 件中 1 から 2 件を表示

主張

出典とともに結論を確認し、項目を開いて証拠を読めます。

事実根拠 1

に投資solar projects

The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.

GlobeNewswire public company news · 2026-10-07 19:32

証拠を見る

企業開示GlobeNewswire public company news2026-10-07 19:32
The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
出典を見る

事実根拠 1

number of solar projects in which it is the lead investorfour

GlobeNewswire public company news · 2026-10-07 19:32

証拠を見る

企業開示GlobeNewswire public company news2026-10-07 19:32
The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
出典を見る

事実根拠 2

を所有MitoCareX Bio

Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.

GlobeNewswire public company news · 2026-10-07 19:32

証拠を見る

企業開示GlobeNewswire public company news2026-10-07 19:32
Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
出典を見る
企業開示GlobeNewswire public company news2026-10-07 19:32
MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
出典を見る

3 件中 1 から 3 件を表示

市場とバリュエーション

バリュエーションは Pro と Research で利用できます。

Pro で解放

利用できません: 企業シグナル · 財務 · 開示資料 · ガイダンス